A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of PRX-03140 as Monotherapy in Subjects With Alzheimer's Disease.

Trial Profile

A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of PRX-03140 as Monotherapy in Subjects With Alzheimer's Disease.

Discontinued
Phase of Trial: Phase II

Latest Information Update: 02 Jun 2011

At a glance

  • Drugs Donepezil; PRX 3140
  • Indications Alzheimer's disease
  • Focus Therapeutic Use
  • Sponsors EPIX Pharmaceuticals
  • Most Recent Events

    • 31 Jul 2009 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
    • 05 Jun 2008 The expected completion date for this trial is Jan 2010 as reported by ClinicalTrials.gov.
    • 05 Jun 2008 Status changed from initiated to recruiting as reported by ClinicalTrials.gov
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top